NASDAQ: APREAprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?
Insider buying vs selling
Have Aprea Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Oren Gilad | PresidentCEO | 2025-04-03 | 3,003 | $1.87 | $5.62kBuy |
| Oren Gilad | PresidentCEO | 2025-04-03 | 2,497 | $1.80 | $4.49kBuy |
| Oren Gilad | PresidentCEO | 2024-10-23 | 500 | $3.92 | $1.96kBuy |
| Marc Duey | Director | 2024-10-18 | 6,462 | $4.58 | $29.58kSell |
| Marc Duey | Director | 2024-10-16 | 30,000 | $4.39 | $131.70kBuy |
| Oren Gilad | PresidentCEO | 2024-10-15 | 250 | $2.90 | $725.00Buy |
| Marc Duey | Director | 2024-10-14 | 190 | $2.58 | $490.20Buy |
| Oren Gilad | PresidentCEO | 2024-10-14 | 1,000 | $2.59 | $2.59kBuy |
| John P. Hamill | SrVPCFOPrin Fin Acct Ofcr | 2024-10-11 | 50 | $2.46 | $123.20Buy |
| Bernd R. Seizinger | Director | 2024-10-11 | 10,000 | $2.68 | $26.80kBuy |
APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when APRE insiders and whales buy or sell their stock.
APRE Shareholders
What type of owners hold Aprea Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tryant LLC | 480.67% | 28,000,000 | $46.06M | Insider |
| Thomas Banks | 229.88% | 13,391,146 | $22.03M | Insider |
| Frank J. Hall | 82.09% | 4,781,889 | $7.87M | Insider |
| David West Wilson | 50.21% | 2,924,726 | $4.81M | Insider |
| Heidi A. Patterson | 46.15% | 2,688,221 | $4.42M | Insider |
| Kdev Investments Ab | 34.21% | 1,992,586 | $3.28M | Insider |
| Michael Reynolds | 33.99% | 1,980,040 | $3.26M | Insider |
| Redmile Group LLC | 30.36% | 1,768,718 | $2.91M | Insider |
| Aigh Capital Management LLC | 9.26% | 539,300 | $887.15k | Institution |
| Oren Gilad | 5.96% | 347,420 | $571.51k | Insider |
APRE vs Biotech Stocks
Aprea Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.